HOME >> BIOLOGY >> NEWS
Livermore & NIH scientists create technique to examine behavior of proteins at single molecule level

LIVERMORE, Calif. -- A Lawrence Livermore National Laboratory physicist, in collaboration with an international team of researchers, has developed an experimental method that allows scientists to investigate the behavior of proteins under non-equilibrium conditions one molecule at a time, to better understand a fundamental biological process of protein folding that is important for many diseases.

The work, presented in the Aug. 29 edition of Science, marks the first time protein-folding kinetics has been monitored on the single-molecule level. Proteins are long chains of amino acids. Like shoelaces, they loop about each other or fold in a variety of ways, and only one way allows the protein to function properly. Just as a knotted shoelace can be a problem, a misfolded protein can do serious damage. Many diseases, such as Alzheimer's, cystic fibrosis, mad cow disease and many cancers result from misfolded protein.

Livermore's Lawrence postdoctoral fellow Olgica Bakajin worked with scientists from the NIDDK Laboratory of Chemical Physics at the National Institute of Health and the Physikalische Biochemie Universitt Postadam in Germany to develop a microfluidic mixer for studies of protein folding. With this mixer, researchers were able to access information about the protein folding reaction that was never available from ensemble measurements or even from the newer single molecule equilibrium measurements.

"For the first time, in this experiment we were able to look at a protein on a single molecule level at defined times after the folding reaction was initiated," Bakajin said. "With this method we are able to see and isolate intermediate states that under equilibrium conditions only exist for a brief period of time.

"This is a fundamental science project. We would like to understand the sequence of events through which a protein goes from a random coil to its functional 'folded' form, and we've designed an instrument that can
'"/>

Contact: Anne Stark
925-422-9799
University of California - Berkeley
28-Aug-2003


Page: 1 2

Related biology news :

1. Livermore research in accelerator mass spectrometry highlighted at ACS meeting
2. Livermore researchers apply combat simulation technology to homeland security
3. NNSAs Livermore Lab partners with cities and counties to track biological, chemical releases
4. Lawrence Livermore research team finds unique DNA signatures to improve anthrax detection
5. Livermore Lab hosts conference on Bioterrorism for the Courts
6. Livermore research team wins distinguished Department of Energy award for development of miniature glucose sensor for diabetes patients
7. Lawrence Livermore Lab, UC Davis Cancer Center ink alliance to develop integrated cancer program
8. UC Davis and Lawrence Livermore National Laboratory seek industry partners to develop new bio and medical technology products
9. DNA lends scientists a hand, revealing new chemical reactions
10. Conference at UH opens doors for new scientists, engineers
11. Wisconsin scientists develop quick botox test

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/31/2020)... ... July 30, 2020 , ... BioFactura, ... contract awarded by the Joint Science & Technology Office—Chemical and Biological Defense (JSTO-CBD) ... develop, optimize, and scale-up a highly efficient mammalian cell culture-based bioprocess suitable to ...
(Date:7/10/2020)... FALLS CHURCH, Va. (PRWEB) , ... July 08, ... ... , The Latest on Cell and Gene Therapy Regulation, An FDAnews Webinar, Wednesday, ... product may need a comparability study, but what is the most effective way ...
(Date:7/1/2020)... N.J. (PRWEB) , ... July 01, 2020 , ... ... announced that it had completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility in ... the company’s existing Japanese clinical supply facility located in Kakegawa, the new 60,000-square-foot ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... July 16, 2020 , ... “We are thrilled to ... Bioactives. “It’s the only technology of its kind on the market and we were ... with the protective capacity of traditional cultured ingredients, creating a natural way to extend ...
(Date:7/18/2020)... TORONTO (PRWEB) , ... July 17, 2020 , ... ... and global consulting firm for the life sciences and food industries, is pleased ... new Director of Clinical Research – Business Development. , Charles is an accomplished ...
(Date:7/10/2020)... , ... July 09, 2020 ... ... company, announced today that Massachusetts Institute of Technology (MIT) has expanded the ... license allows PathSensors to move into the point-of-care diagnostic market, focusing initially ...
(Date:7/10/2020)... ... July 09, 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage ... Allen R. Nissenson, M.D., F.A.C.P., as its Chief Medical Officer. Dr. Nissenson ... product, SBI-101. Dr. Nissenson serves as an Emeritus Professor of Medicine at ...
Breaking Biology Technology:
Cached News: